Your browser doesn't support javascript.
Impact of electronic cigarette and heated tobacco product on conventional smoking: an Italian prospective cohort study conducted during the COVID-19 pandemic.
Gallus, Silvano; Stival, Chiara; McKee, Martin; Carreras, Giulia; Gorini, Giuseppe; Odone, Anna; van den Brandt, Piet A; Pacifici, Roberta; Lugo, Alessandra.
  • Gallus S; Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy silvano.gallus@marionegri.it.
  • Stival C; Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • McKee M; London School of Hygiene & Tropical Medicine, London, UK.
  • Carreras G; Oncologic Network, Prevention and Research Institute, Florence, Italy.
  • Gorini G; Oncologic Network, Prevention and Research Institute, Florence, Italy.
  • Odone A; Department of Public Health, Experimental and Forensic Medicine, University of Pavia Faculty of Medicine and Surgery, Pavia, Italy.
  • van den Brandt PA; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
  • Pacifici R; Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
  • Lugo A; Department of Epidemiology, CAPHRI-School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands.
Tob Control ; 2022 Oct 07.
Article in English | MEDLINE | ID: covidwho-2064283
ABSTRACT

OBJECTIVE:

Debate continues about whether electronic cigarettes (e-cigarettes) and heated tobacco products (HTP) reduce or increase the probability of smoking, with many studies compromised by stated or unstated conflicts of interest. We undertook a longitudinal study in Italy.

METHODS:

3185 Italian participants aged 18-74 years provided baseline (April-May) and follow-up (November-December) responses in 2020, reporting smoking status and use of e-cigarettes and HTP. We tracked transitions over that period and reported risk ratios (RR) and corresponding 95% CIs for changes in smoking in relation to baseline use of e-cigarettes and HTPs.

RESULTS:

Never cigarette smokers who used e-cigarettes at baseline were much more likely to start smoking (compared with never users, RR 8.78; 95% CI 5.65 to 13.65) and current HTP users (RR 5.80; 95% CI 3.65 to 9.20). Among ex-smokers, relapse (17.2%) at follow-up was more likely among e-cigarette (RR 4.25; 95% CI 2.40 to 7.52) and HTP users (RR 3.32; 95% CI 2.05 to 5.37). Among current smokers at baseline, those who had continued smoking at follow-up were 85.4% overall. These were more frequently current novel product users (compared with non-users, RR 1.10; 95% CI 1.02 to 1.19 for e-cigarette users; RR 1.17; 95% CI 1.10 to 1.23 for HTP users).

CONCLUSIONS:

Both e-cigarette and HTP use predict starting smoking and relapse, and appear to reduce smoking cessation. Due to the limited sample size within specific strata, the association with quitting smoking should be confirmed by larger prospective studies. These findings do not support the use of e-cigarettes and HTPs in tobacco control as a consumer product, at least in Italy.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Language: English Journal subject: Substance-Related Disorders Year: 2022 Document Type: Article Affiliation country: Tc-2022-057368

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Language: English Journal subject: Substance-Related Disorders Year: 2022 Document Type: Article Affiliation country: Tc-2022-057368